STOCK TITAN
  1. Home
  2. Sec-filings
  3. BTAI
  4. [Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BTAI logo
Bioxcel Therapeutics Inc

NASDAQ:BTAI

BTAI Rankings

#5345 Ranked by Market Cap
N/A Ranked by Dividends

BTAI Latest News

Sep 18, 2025
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
Sep 10, 2025
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
Sep 4, 2025
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 27, 2025
BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®
Aug 26, 2025
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

BTAI Latest SEC Filings

Sep 15, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

BTAI Stock Data

53.05M
19.08M
3.8%
6.23%
25.27%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN